Cargando…
Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders
Throughout the COVID-19 pandemic, international access to COVID-19 vaccines and other health technologies has remained highly asymmetric. This inequity has had a particularly deleterious impact on low- and middle-income countries, engaging concerns about the human rights to health and to the equal e...
Autores principales: | Kohler, Jillian, Wong, Anna, Tailor, Lauren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harvard University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790937/ https://www.ncbi.nlm.nih.gov/pubmed/36579316 |
Ejemplares similares
-
US Support for a WTO Waiver of COVID-19 Intellectual Property
por: Contreras, Jorge L.
Publicado: (2021) -
The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access
por: Esmail, Laura C, et al.
Publicado: (2012) -
Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
por: Hashemi Meshkini, Amir, et al.
Publicado: (2012) -
COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform
por: Chattu, Vijay Kumar, et al.
Publicado: (2021) -
WTO accession and firm exports in developing economies
por: Nuruzzaman, N., et al.
Publicado: (2021)